Biomerica Inc.
- Share via
The Newport Beach medical technology company said it lost $513,845, or 11 cents a share, for its fiscal third-quarter, compared with a net loss of $886,262, or 20 cents a share, for the corresponding period last year. Sales for the quarter ended Feb. 28 were up 28% to $2.3 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
